Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4153)
All Articles published online
|
Dec 21, 2009 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, Sui CJ, Yang JM. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 2009; 15(47): 5976-5982 [PMID: PMC2795186 DOI: 10.3748/wjg.15.5976] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i47/5976.htm |
| Number | Citing Articles |
| 1 |
Shigeru Marubashi, Kunihito Gotoh, Hidenori Takahashi, Hiroaki Ohigashi, Masahiko Yano, Osamu Ishikawa, Masato Sakon. Prediction of the Postoperative Prognosis of Intrahepatic Cholangiocarcinoma (ICC): Importance of Preoperatively-Determined Anatomic Invasion Level and Number of Tumors. Digestive Diseases and Sciences 2014; 59(1): 201 doi: 10.1007/s10620-013-2894-4
|
| 2 |
B. Joseph Elmunzer, Jennifer L. Maranki, Victoria Gómez, Anna Tavakkoli, Bryan G. Sauer, Berkeley N. Limketkai, Emily A. Brennan, Elaine M. Attridge, Tara J. Brigham, Andrew Y. Wang. ACG Clinical Guideline: Diagnosis and Management of Biliary Strictures. American Journal of Gastroenterology 2023; 118(3): 405 doi: 10.14309/ajg.0000000000002190
|
| 3 |
Jinxin Sheng, Ri Wang, Haifan Yang, Zhong Zhao, Shichen Qin, Jie Yao, Guang Yang, Xiaowei Cao, Xinghai Yang, Xiaoyong Wang. Surface-enhanced Raman scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins. Photodiagnosis and Photodynamic Therapy 2024; 49: 104336 doi: 10.1016/j.pdpdt.2024.104336
|
| 4 |
Cholangiocarcinoma diagnosis and treatment. Asian Biomedicine 2024; 18(2): 35 doi: 10.2478/abm-2024-0007
|
| 5 |
Stevan A. Gonzalez, Emmet B. Keeffe. Diagnosis of Hepatocellular Carcinoma: Role of Tumor Markers and Liver Biopsy. Clinics in Liver Disease 2011; 15(2): 297 doi: 10.1016/j.cld.2011.03.012
|
| 6 |
Clancy J. Clark, Christina M. Wood-Wentz, Kaye M. Reid-Lombardo, Michael L. Kendrick, Marianne Huebner, Florencia G. Que. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB 2011; 13(9): 612 doi: 10.1111/j.1477-2574.2011.00340.x
|
| 7 |
Changzheng Wang, Shujie Pang, Hui Si-Ma, Ning Yang, Haibin Zhang, Yong Fu, Guangshun Yang. Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-018-1540-1
|
| 8 |
Maria Chiara Brunese, Maria Rita Fantozzi, Roberta Fusco, Federica De Muzio, Michela Gabelloni, Ginevra Danti, Alessandra Borgheresi, Pierpaolo Palumbo, Federico Bruno, Nicoletta Gandolfo, Andrea Giovagnoni, Vittorio Miele, Antonio Barile, Vincenza Granata. Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma. Diagnostics 2023; 13(8): 1488 doi: 10.3390/diagnostics13081488
|
| 9 |
Akshat Saxena, Terence C. Chua, Anik Sarkar, Francis Chu, David L. Morris. Clinicopathologic and Treatment-Related Factors Influencing Recurrence and Survival after Hepatic Resection of Intrahepatic Cholangiocarcinoma: A 19-Year Experience from an Established Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery 2010; 14(7): 1128 doi: 10.1007/s11605-010-1203-1
|
| 10 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; : 1105 doi: 10.2147/JHC.S341195
|
| 11 |
Shuang Chen, Lijuan Wan, Rui Zhao, Wenjing Peng, Xiangchun Liu, Lin Li, Hongmei Zhang. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma. Abdominal Radiology 2023; 49(2): 425 doi: 10.1007/s00261-023-04079-6
|
| 12 |
Ka Wing Ma, Tan To Cheung, Wong Hoi She, Kenneth S.H. Chok, Albert Chi Yan Chan, Irene Oi Lin Ng, See Ching Chan, Chung Mau Lo. The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma. Medicine 2016; 95(28): e4133 doi: 10.1097/MD.0000000000004133
|
| 13 |
Dong Hun Kim, Dong Wook Choi, Seong Ho Choi, Jin Seok Heo, Alfred Wei-Chieh Kow. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Surgery 2015; 157(4): 666 doi: 10.1016/j.surg.2014.11.006
|
| 14 |
Robert J. Wong, Aijaz Ahmed, Robert G. Gish. Elevated Alpha-Fetoprotein. Clinics in Liver Disease 2015; 19(2): 309 doi: 10.1016/j.cld.2015.01.005
|
| 15 |
Mami Hamaoka, Kazuto Kozaka, Osamu Matsui, Takahiro Komori, Takashi Matsubara, Norihide Yoneda, Kotaro Yoshida, Dai Inoue, Azusa Kitao, Wataru Koda, Toshifumi Gabata, Satoshi Kobayashi. Early detection of intrahepatic cholangiocarcinoma. Japanese Journal of Radiology 2019; 37(10): 669 doi: 10.1007/s11604-019-00860-0
|
| 16 |
Gui-Min Hou, Hai-ling Liu, Hong Wu, Yong Zeng. Prediction of Prognosis for cHCC-CC Patients After Surgery: Comparison of Tumor Marker Score Based on AFP, CEA, CA19-9, and Other Clinical Stages. Annals of Surgical Oncology 2021; 28(12): 7647 doi: 10.1245/s10434-021-09949-1
|
| 17 |
Miao-Erh Chang, Hao-Jan Lei, Ming-Huang Chen, Yi-Chen Yeh, Chung-Pin Li, Yi-Ping Hung, Cheng-Yuan Hsia, Chieu-An Liu, Gar-Yang Chau, Yee Chao. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. Journal of the Chinese Medical Association 2017; 80(3): 140 doi: 10.1016/j.jcma.2016.09.010
|
| 18 |
Arezou Abbasi, Amir A. Rahnemai-Azar, Sean M. Ronnekleiv-Kelly, Daniel E. Abbott, Sharon M. Weber. Intrahepatic Cholangiocarcinoma. 2019; : 11 doi: 10.1007/978-3-030-22258-1_2
|
| 19 |
Mélanie Vallin, Nathalie Sturm, Géraldine Lamblin, Olivier Guillaud, Marie‐Noëlle Hilleret, Valérie Hervieu, Juliette Joubert, Armand Abergel, Vincent Leroy, Olivier Boillot, Jérôme Dumortier, Jean‐Yves Scoazec. Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants. Clinical Transplantation 2013; 27(3): 403 doi: 10.1111/ctr.12108
|
| 20 |
Alok Ghosh Chaudhuri, Saptadip Samanta, Monalisha Dey, N. S. Raviraja, Souvik Dey.
Role of Alpha-Fetoprotein in the Pathogenesis of Cancer
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(2): 57 doi: 10.1615/JEnvironPatholToxicolOncol.2023049145
|
| 21 |
Alexander S. Williams, Michael A. Sikes, Scott Liu. An Unusual Case of Intrahepatic Stone Masquerading as Cholangiocarcinoma. ACG Case Reports Journal 2025; 12(2): e01607 doi: 10.14309/crj.0000000000001607
|
| 22 |
Peter J. Kneuertz, Lillian S. Kao, Tien C. Ko, Curtis J. Wray. Regional disparities affect treatment and survival of patients with intrahepatic cholangiocarcinoma-A Texas Cancer Registry analysis. Journal of Surgical Oncology 2014; 110(4): 416 doi: 10.1002/jso.23664
|
| 23 |
Ranish K. Patel, Michael S. Parappilly, Brett S. Walker, Robert T. Heussner, Alice Fung, Young Hwan Chang, Adel Kardosh, Charles D. Lopez, Skye C. Mayo, Melissa H. Wong. Exploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences 2024; 25(17): 9198 doi: 10.3390/ijms25179198
|
| 24 |
Denis Chatelain, Olivier Farges, David Fuks, Nathalie Trouillet, François René Pruvot, Jean-Marc Regimbeau. Assessment of pathology reports on hilar cholangiocarcinoma: The results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. Journal of Hepatology 2012; 56(5): 1121 doi: 10.1016/j.jhep.2011.12.010
|
| 25 |
Lipika Goyal, Aparna Govindan, Rahul A. Sheth, Valentina Nardi, Lawrence S. Blaszkowsky, Jason E. Faris, Jeffrey W. Clark, David P. Ryan, Eunice L. Kwak, Jill N. Allen, Janet E. Murphy, Supriya K. Saha, Theodore S. Hong, Jennifer Y. Wo, Cristina R. Ferrone, Kenneth K. Tanabe, Dawn Q. Chong, Vikram Deshpande, Darrell R. Borger, A. John Iafrate, Nabeel Bardeesy, Hui Zheng, Andrew X. Zhu. Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma. The Oncologist 2015; 20(9): 1019 doi: 10.1634/theoncologist.2015-0210
|
| 26 |
Olivia Jones, Xiaoqian Cheng, Saravana R. K. Murthy, Lawan Ly, Taisen Zhuang, Giacomo Basadonna, Michael Keidar, Jerome Canady. The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88451-w
|
| 27 |
Zhizhen Li, Qingxiang Gao, Yingjun Wu, Xiaoming Ma, Fangyan Wu, Siyu Luan, Sunrui Chen, Siyuan Shao, Yang Shen, Ding Zhang, Feiling Feng, Lei Yuan, Shaohua Wei. HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma. Hepatology Communications 2024; 8(1) doi: 10.1097/HC9.0000000000000360
|
| 28 |
Hou-Chuan Lai, Meei-Shyuan Lee, Kuen-Tze Lin, Shun-Ming Chan, Jen-Yin Chen, Yao-Tsung Lin, Zhi-Fu Wu. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery. Medicine 2019; 98(51): e18472 doi: 10.1097/MD.0000000000018472
|
| 29 |
Junyi Shen, Tianfu Wen, Chuan Li, Lvnan Yan, Bo Li, Jiayin Yang. The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following Hepatectomy. Digestive Diseases 2018; 36(4): 306 doi: 10.1159/000487479
|
| 30 |
Nicole Cheng, Nathanelle Khoo, Alexander Y. F. Chung, Brian K. P. Goh, Peng Chung Cheow, Pierce K. H. Chow, Ser Yee Lee, London L. Ooi, Prema Raj Jeyaraj, Juinn Huar Kam, Ye Xin Koh, Chung Yip Chan, Jin Yao Teo. Pre‐operative Imaging Characteristics in Histology‐Proven Resected Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2020; 44(11): 3862 doi: 10.1007/s00268-020-05698-6
|
| 31 |
Ming-An Yu, Ping Liang, Xiao-Ling Yu, Zhi-Gang Cheng, Zhi-Yu Han, Fang-Yi Liu, Jie Yu. Liver abscess as a complication of microwave ablation for liver metastatic cholangiocarcinoma after bilioenteric anastomosis. International Journal of Hyperthermia 2011; 27(5): 503 doi: 10.3109/02656736.2011.555876
|
| 32 |
Carlo Sposito, Michele Droz dit Busset, Matteo Virdis, Davide Citterio, Maria Flores, Marco Bongini, Monica Niger, Vincenzo Mazzaferro. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review. European Journal of Surgical Oncology 2022; 48(1): 150 doi: 10.1016/j.ejso.2021.08.009
|
| 33 |
Boris Blechacz, Mina Komuta, Tania Roskams, Gregory J. Gores. Clinical diagnosis and staging of cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2011; 8(9): 512 doi: 10.1038/nrgastro.2011.131
|
| 34 |
Zeyuan Qiang, Wenhua Zhang, Shuai Jin, Kunfu Dai, Yuting He, Lianyuan Tao, Haibo Yu. Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study. Annals of Hepatology 2021; 20: 100242 doi: 10.1016/j.aohep.2020.07.010
|
| 35 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_188-1
|
| 36 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
| 37 |
Olivier Farges, David Fuks, Emmanuel Boleslawski, Yves-Patrice Le Treut, Denis Castaing, Alexis Laurent, Christian Ducerf, Michel Rivoire, Philippe Bachellier, Laurence Chiche, Gennaro Nuzzo, Jean Marc Regimbeau. Influence of Surgical Margins on Outcome in Patients With Intrahepatic Cholangiocarcinoma. Annals of Surgery 2011; 254(5): 824 doi: 10.1097/SLA.0b013e318236c21d
|
| 38 |
Zachary J. Brown, D. Brock Hewitt, Timothy M. Pawlik. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy. Frontiers in Bioscience-Landmark 2022; 27(3) doi: 10.31083/j.fbl2703085
|
| 39 |
Kimberly M. Brown, David A. Geller. Proximal Biliary Tumors. Surgical Clinics of North America 2014; 94(2): 311 doi: 10.1016/j.suc.2013.12.003
|
| 40 |
Ming-An Yu, Ping Liang, Xiao-Ling Yu, Zhi-Gang Cheng, Zhi-Yu Han, Fang-Yi Liu, Jie Yu. Sonography-guided percutaneous microwave ablation of intrahepatic primary cholangiocarcinoma. European Journal of Radiology 2011; 80(2): 548 doi: 10.1016/j.ejrad.2011.01.014
|
| 41 |
Ze-Wu Meng, Xiu-Quan Lin, Jin-Hai Zhu, Sheng-Hua Han, Yan-Ling Chen. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma. Journal of Surgical Research 2018; 226: 56 doi: 10.1016/j.jss.2018.01.024
|
| 42 |
Kelly Lafaro, Miral Sadaria Grandhi, Joseph M. Herman, Timothy M. Pawlik. The importance of surgical margins in primary malignancies of the liver. Journal of Surgical Oncology 2016; 113(3): 296 doi: 10.1002/jso.24123
|
| 43 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 549 doi: 10.1007/978-3-319-26956-6_29
|
| 44 |
Kota Sahara, Diamantis I. Tsilimigras, Rittal Mehta, Fabio Bagante, Alfredo Guglielmi, Luca Aldrighetti, Sorin Alexandrescu, Hugo P. Marques, Feng Shen, Bas G. Koerkamp, Itaru Endo, Timothy M. Pawlik. A novel online prognostic tool to predict long‐term survival after liver resection for intrahepatic cholangiocarcinoma: The “metro‐ticket” paradigm. Journal of Surgical Oncology 2019; 120(2): 223 doi: 10.1002/jso.25480
|
| 45 |
Hideaki Sueoka, Tadamichi Hirano, Yugo Uda, Yuji Iimuro, Junichi Yamanaka, Jiro Fujimoto. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma. Surgery 2014; 155(4): 640 doi: 10.1016/j.surg.2013.12.037
|
| 46 |
Masakazu Yamamoto, Shun-ichi Ariizumi. Surgical outcomes of intrahepatic cholangiocarcinoma. Surgery Today 2011; 41(7): 896 doi: 10.1007/s00595-011-4517-z
|
| 47 |
Biao Gao, Yafei Wang, Xianzhou Zhang, Hao Jiang, Feng Han, Chonghui Li, Shichun Lu. Identification and validation of inflammatory subtypes in intrahepatic cholangiocellular carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05529-5
|
| 48 |
Georgi Atanasov, Moritz Schmelzle, Armin Thelen, Georg Wiltberger, Hans-Michael Hau, Felix Krenzien, Tim-Ole Petersen, Michael Moche, Sven Jonas. Selective hypertrophy of the lobus caudatus as a novel approach enabling extended right hepatectomy in the presence of a non-perfused left lateral liver lobe. Clinical Journal of Gastroenterology 2014; 7(4): 370 doi: 10.1007/s12328-014-0511-5
|
| 49 |
Massimiliano Cadamuro, Ahmad Al-Taee, Tamas A. Gonda. Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma. Journal of Hepatology 2023; 78(5): 1063 doi: 10.1016/j.jhep.2023.01.027
|
| 50 |
Lei Yuan, Xianwu Luo, Xinyuan Lu, Bin Huang, Quanyu Cai. Liver resection for intrahepatic cholangiocarcinoma in AJCC-stage IV: An evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification. Oncology Reports 2016; 36(5): 2663 doi: 10.3892/or.2016.5103
|
| 51 |
W. Z. Xu, X. P. Deng, B. C. Xu. Effects of water stress and fertilization on leaf gas exchange and photosynthetic light-response curves of Bothriochloa ischaemum L.. Photosynthetica 2013; 51(4): 603 doi: 10.1007/s11099-013-0061-y
|
| 52 |
Sameer H. Patel, David A. Kooby, Charles A. Staley, Juan M. Sarmiento, Shishir K. Maithel. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?. HPB 2011; 13(9): 605 doi: 10.1111/j.1477-2574.2011.00335.x
|
| 53 |
Tomohiko Adachi, Susumu Eguchi. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(3): 162 doi: 10.1002/jhbp.30
|
| 54 |
SHOULI WANG, JIKAI YIN, TAO LI, LIJUAN YUAN, DONG WANG, JIAXING HE, XILIN DU, JIANGUO LU. Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma. Oncology Reports 2015; 33(2): 819 doi: 10.3892/or.2014.3641
|
| 55 |
Jonathan G. Navarro, Jin Ho Lee, Incheon Kang, Seoung Yoon Rho, Gi Hong Choi, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?. HPB 2020; 22(10): 1411 doi: 10.1016/j.hpb.2020.01.009
|
| 56 |
Malcolm H. Squires, Jordan M. Cloyd, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 2018; 12(7): 671 doi: 10.1080/17474124.2018.1489229
|
| 57 |
Heather N. Simpson, Brendan M. McGuire. Screening and Detection of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 295 doi: 10.1016/j.cld.2015.01.004
|
| 58 |
Masaki Kaibori, Kengo Yoshii, Kosuke Kashiwabara, Takashi Kokudo, Kiyoshi Hasegawa, Namiki Izumi, Takamichi Murakami, Masatoshi Kudo, Shuichiro Shiina, Michiie Sakamoto, Osamu Nakashima, Yutaka Matsuyama, Susumu Eguchi, Tatsuya Yamashita, Tadatoshi Takayama, Norihiro Kokudo, Shoji Kubo. Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey. Hepatology Research 2021; 51(8): 890 doi: 10.1111/hepr.13676
|
| 59 |
Seiki Tashiro, Tatsuya Tsuji, Hidenori Miyake, Hitomi Kamo, Yuko Sumise, Shigeharu Takai, Kazuo Yoshioka. Strategy for improving the prognosis of patients with intrahepatic cholangiocarcinoma by surgical treatment : Considerations based on experience and a literature review. The Journal of Medical Investigation 2021; 68(1.2): 15 doi: 10.2152/jmi.68.15
|
| 60 |
Hira Hanif, Mukarram Jamat Ali, Ammu T Susheela, Iman Waheed Khan, Maria Alejandra Luna-Cuadros, Muzammil Muhammad Khan, Daryl Tan-Yeung Lau. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(2): 216-229 doi: 10.3748/wjg.v28.i2.216
|
| 61 |
|
| 62 |
Sivesh K. Kamarajah. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis. Journal of Gastrointestinal Cancer 2019; 50(3): 392 doi: 10.1007/s12029-018-0084-5
|
| 63 |
Deyao Zhang, Huilan Zeng, Yangxun Pan, Yumo Zhao, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu, Minshan Chen, Dandan Hu. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery. Journal of Personalized Medicine 2022; 12(12): 2041 doi: 10.3390/jpm12122041
|
| 64 |
Toru Yamada, Yoshitsugu Nakanishi, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji, Toshimichi Asano, Kimitaka Tanaka, Yo Kurashima, Yuma Ebihara, Soichi Murakami, Toshiaki Shichinohe, Tomoko Mitsuhashi, Satoshi Hirano. Impact of serum carbohydrate antigen 19‐9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2018; 33(9): 1626 doi: 10.1111/jgh.14124
|
| 65 |
Kota Sahara, Diamantis I. Tsilimigras, Katiuscha Merath, Fabio Bagante, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, George A. Poultsides, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, Olivier Soubrane, B. Groot Koerkamp, Ryusei Matsuyama, Itaru Endo, Timothy M. Pawlik. Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?. Annals of Surgical Oncology 2019; 26(9): 2959 doi: 10.1245/s10434-019-07483-9
|
| 66 |
Sudarat Sriputtha, Narong Khuntikeo, Supannee Promthet, Supot Kamsaard. Survival Rate of Intrahepatic Cholangiocarcinoma Patients after Surgical Treatment in Thailand. Asian Pacific Journal of Cancer Prevention 2013; 14(2): 1107 doi: 10.7314/APJCP.2013.14.2.1107
|
| 67 |
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
|
| 68 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_36-1
|
| 69 |
Rui Zhou, Dihan Lu, Wenda Li, Wenliang Tan, Sicong Zhu, Xianqing Chen, Jun Min, Changzhen Shang, Yajin Chen. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB 2019; 21(7): 784 doi: 10.1016/j.hpb.2018.12.011
|
| 70 |
Zheng Wang, Yuan-Yuan Sheng, Qiong-Zhu Dong, Lun-Xiu Qin. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. World Journal of Gastroenterology 2016; 22(10): 3038-3051 doi: 10.3748/wjg.v22.i10.3038
|
| 71 |
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi. Topics in the Surgery of the Biliary Tree. 2018; doi: 10.5772/intechopen.75516
|
| 72 |
Changhe Zhang, Hong Xu, Zhenping Zhou, Ye Tian, Xiaofei Cao, Guochang Cheng, Qinghong Liu. Blocking of the EGFR‑STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6038
|
| 73 |
W. Jiang, Z.-C. Zeng, Z.- Y. Tang, J. Fan, H.-C. Sun, J. Zhou, M.-S. Zeng, B.-H. Zhang, Y. Ji, Y.-X. Chen. A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Annals of Oncology 2011; 22(7): 1644 doi: 10.1093/annonc/mdq650
|
| 74 |
Tomohide Nakayama, Takahiro Tsuchikawa, Toshiaki Shichinohe, Toru Nakamura, Yuma Ebihara, Satoshi Hirano. Pathological Confirmation of Para‐Aortic Lymph Node Status as a Potential Criterion for the Selection of Intrahepatic Cholangiocarcinoma Patients for Radical Resection with Regional Lymph Node Dissection. World Journal of Surgery 2014; 38(7): 1763 doi: 10.1007/s00268-013-2433-7
|
| 75 |
Kimberly M. Brown, Abhishek D. Parmar, David A. Geller. Intrahepatic Cholangiocarcinoma. Surgical Oncology Clinics of North America 2014; 23(2): 231 doi: 10.1016/j.soc.2013.10.004
|
| 76 |
Shang-Long Liu, Zi-Fang Song, Qing-Gang Hu, Duo Shan, Shao-Bo Hu, Jun Li, Qi-Chang Zheng. Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis. Frontiers of Medicine in China 2010; 4(4): 457 doi: 10.1007/s11684-010-0240-1
|
| 77 |
He Guowei, Liao Yuan, Li Ma, Liu Zhongyang, Song Zhixing, Li Lin, Luo Minqi. The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 266 doi: 10.1016/j.clinre.2018.10.010
|
| 78 |
Hari Nathan, Timothy M Pawlik. Staging of intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology 2010; 26(3): 269 doi: 10.1097/MOG.0b013e328337c899
|
| 79 |
Zichen Bian, Jialin Meng, Qingsong Niu, Xiaoyan Jin, Jinian Wang, Xingliang Feng, Hong Che, Jun Zhou, Li Zhang, Meng Zhang, Chaozhao Liang. <p>Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer</p>. Cancer Management and Research 2020; : 8481 doi: 10.2147/CMAR.S264856
|
| 80 |
Chaobin He, Yize Mao, Jun Wang, Yunda Song, Xin Huang, Xiaojun Lin, Shengping Li. The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. Journal of Gastrointestinal Surgery 2018; 22(7): 1239 doi: 10.1007/s11605-018-3756-3
|
| 81 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3501 doi: 10.1007/978-3-319-26956-6_188
|
| 82 |
Najib Ben Khaled, Sven Jacob, Daniel Rössler, Florian Bösch, Enrico N. De Toni, Jens Werner, Jens Ricke, Julia Mayerle, Max Seidensticker, Christian Schulz, Matthias P. Fabritius. Current State of Multidisciplinary Treatment in Cholangiocarcinoma. Digestive Diseases 2022; 40(5): 581 doi: 10.1159/000520346
|
| 83 |
Kheman Rajkomar, Jonathan B. Koea. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 805 doi: 10.1016/B978-0-323-34062-5.00050-9
|
| 84 |
Jie Cao, Liang Huang, Caifeng Liu, Jing Li, Xianghua Zhang, Jun Shen, Jun Li, Lun Lu, Feng Xu, Jianjun Yan, Mengchao Wu, Wan Yee Lau, Yiqun Yan. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A clinicopathologic study of 35 resected cases. Journal of Gastroenterology and Hepatology 2013; 28(6): 1025 doi: 10.1111/jgh.12143
|
| 85 |
Rebecca M. Dodson, Matthew J. Weiss, David Cosgrove, Joseph M. Herman, Ihab Kamel, Robert Anders, Jean-Francois H. Geschwind, Timothy M. Pawlik. Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies. Journal of the American College of Surgeons 2013; 217(4): 736 doi: 10.1016/j.jamcollsurg.2013.05.021
|
| 86 |
Kazuhisa Uchiyama, Masakazu Yamamoto, Hiroki Yamaue, Shun‐ichi Ariizumi, Taku Aoki, Norihiro Kokudo, Tomoki Ebata, Masato Nagino, Masayuki Ohtsuka, Masaru Miyazaki, Eiichi Tanaka, Satoshi Kondo, Takahiro Uenishi, Shoji Kubo, Hiroshi Yoshida, Michiaki Unno, Satoru Imura, Mitsuo Shimada, Masaki Ueno, Tadahiro Takada. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery. Journal of Hepato-Biliary-Pancreatic Sciences 2011; 18(3): 443 doi: 10.1007/s00534-010-0349-2
|
| 87 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 699 doi: 10.1007/978-3-319-26956-6_36
|
| 88 |
Mohamed Abdel-Wahab, Ahmed Shehta. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 421 doi: 10.1007/978-981-19-0063-1_57
|
| 89 |
Shun-ichi Ariizumi, Masakazu Yamamoto. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis. Surgery Today 2015; 45(6): 682 doi: 10.1007/s00595-014-1031-0
|
| 90 |
Kimberly M. Brown, David A. Geller. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 241 doi: 10.1007/978-3-642-40558-7_15
|
| 91 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
|
| 92 |
Tian-Run Lv, Fei Liu, Yan-Wen Jin, Hai-Jie Hu, Wen-Jie Ma, Fu-Yu Li. Meta-analysis of Prognostic Factors for Overall Survival Among Resected Patients with Spontaneous Ruptured Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2023; 27(12): 2983 doi: 10.1007/s11605-023-05860-0
|